Lyka Labs Ltd

₹ 120 -2.21%

03 May 11:21 a.m.

About

Incorporated in 1976, Lyka Labs Ltd is in the development, manufacture and marketing of quality finished dosages^[1]

Key Points

Business Overview:^[1]
LLL is a WHO-GMP certified and ISO 9001- certified manufacturer of Pharmaceutical Formulations & Active Pharmaceutical Ingredients across various therapeutic segments, including Lyophilized injections, topical formulations of cream, ointment, foams, gels & lotions.

Website BSE NSE

Market Cap ₹ 395 Cr.
Current Price ₹ 120
High / Low ₹ 144 / 88.5
Stock P/E
Book Value ₹ 30.1
Dividend Yield 0.00 %
ROCE 3.60 %
ROE -12.0 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company has reduced debt.
Company has a good return on equity (ROE) track record: 3 Years ROE 27.0%
Promoter holding has increased by 3.29% over last quarter.

Cons

Company has low interest coverage ratio.
Debtor days have increased from 58.3 to 77.7 days.
Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	18.91	17.82	43.47	65.02	28.18	27.68	21.88	22.13	17.13	19.46	21.24	26.76	31.42
	14.30	12.35	13.66	20.82	16.25	16.12	15.96	17.40	14.91	16.73	18.69	22.82	25.56
Operating Profit	4.61	5.47	29.81	44.20	11.93	11.56	5.92	4.73	2.22	2.73	2.55	3.94	5.86
OPM %	24.38%	30.70%	68.58%	67.98%	42.33%	41.76%	27.06%	21.37%	12.96%	14.03%	12.01%	14.72%	18.65%
	0.75	-0.85	0.53	-1.18	0.85	-2.14	0.68	0.90	-5.79	0.47	0.43	0.25	0.52
Interest	6.53	6.31	6.89	5.53	4.60	2.91	2.80	2.91	3.04	2.81	1.33	1.17	1.26
Depreciation	2.05	1.95	2.05	2.09	2.12	9.13	3.41	3.46	3.33	3.32	3.34	3.46	2.72
Profit before tax	-3.22	-3.64	21.40	35.40	6.06	-2.62	0.39	-0.74	-9.94	-2.93	-1.69	-0.44	2.40
Tax %	4.66%	106.59%	8.18%	15.79%	6.27%	-481.30%	15.38%	45.95%	-2.82%	-2.39%	-2.37%	34.09%	43.33%
	-3.06	0.23	19.65	29.81	5.68	-15.24	0.33	-0.40	-10.21	-3.01	-1.72	-0.29	1.36
EPS in Rs	-1.07	0.08	6.85	10.39	1.98	-5.31	0.12	-0.14	-3.56	-0.98	-0.52	-0.09	0.41
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2012	Mar 2013	Jun 2014	Jun 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
	139.81	94.52	86.57	90.49	57.27	78.01	41.68	41.18	40.74	62.26	164.35	80.59	98.88
	131.56	81.96	88.41	72.16	49.34	56.25	42.20	40.16	43.95	47.84	66.85	64.99	83.80
Operating Profit	8.25	12.56	-1.84	18.33	7.93	21.76	-0.52	1.02	-3.21	14.42	97.50	15.60	15.08
OPM %	5.90%	13.29%	-2.13%	20.26%	13.85%	27.89%	-1.25%	2.48%	-7.88%	23.16%	59.32%	19.36%	15.25%
	14.05	3.98	23.97	5.22	10.97	-0.25	3.37	2.05	-25.16	0.78	-1.95	-3.72	1.67
Interest	22.56	16.04	23.97	18.35	11.44	16.54	7.76	5.73	19.01	25.55	19.92	11.57	6.57
Depreciation	5.46	3.30	5.43	3.83	2.64	5.53	6.31	4.44	7.77	8.05	15.39	13.52	12.84
Profit before tax	-5.72	-2.80	-7.27	1.37	4.82	-0.56	-11.22	-7.10	-55.15	-18.40	60.24	-13.21	-2.66
Tax %	0.00%	0.00%	0.00%	0.00%	0.00%	66.07%	3.39%	124.37%	-0.44%	21.41%	33.76%	-0.61%
	-5.71	-2.80	-7.27	1.37	4.82	-0.19	-10.84	1.73	-55.39	-14.46	39.90	-13.29	-3.66
EPS in Rs	-2.65	-1.30	-3.37	0.63	2.19	-0.09	-3.85	0.61	-19.31	-5.04	13.91	-4.33	-1.18
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	-2%
5 Years:	14%
3 Years:	26%
TTM:	11%

Compounded Profit Growth
10 Years:	%
5 Years:	8%
3 Years:	21%
TTM:	88%

Stock Price CAGR
10 Years:	26%
5 Years:	36%
3 Years:	39%
1 Year:	19%

Return on Equity
10 Years:	%
5 Years:	-1%
3 Years:	27%
Last Year:	-12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2012	Mar 2013	Jun 2014	Jun 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Sep 2023
Equity Capital	21.58	21.58	21.58	21.58	22.04	22.04	28.14	28.14	28.69	28.69	28.69	30.69	33.09
Reserves	51.55	45.40	40.08	38.18	43.38	51.57	67.89	69.71	-9.91	-24.28	15.75	28.30	66.42
Preference Capital	1.09	1.09	1.09	1.09	1.09	0.00	0.87	0.90	0.64	0.71	0.78	1.08
	106.30	128.23	138.65	107.74	104.62	112.10	100.78	90.44	136.23	161.95	128.27	73.36	51.87
	59.75	52.23	62.21	65.62	57.99	57.07	48.00	60.41	66.25	47.01	35.80	46.51	28.38
Total Liabilities	239.18	247.44	262.52	233.12	228.03	242.78	244.81	248.70	221.26	213.37	208.51	178.86	179.76
	83.77	95.46	93.83	61.67	60.26	86.27	81.16	76.23	101.65	95.34	90.11	65.53	60.97
CWIP	18.83	15.38	21.78	27.03	30.17	24.23	26.43	29.71	26.40	24.40	17.74	16.23	17.08
Investments	20.22	20.22	62.53	62.57	62.57	62.45	62.45	62.46	32.41	32.41	32.41	32.41	32.41
	116.36	116.38	84.38	81.85	75.03	69.83	74.77	80.30	60.80	61.22	68.25	64.69	69.30
Total Assets	239.18	247.44	262.52	233.12	228.03	242.78	244.81	248.70	221.26	213.37	208.51	178.86	179.76

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2012	Mar 2013	Jun 2014	Jun 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
	-7.23	13.87	55.37	29.08	7.70	20.17	6.84	18.31	-11.45	5.75	76.53	6.87
	8.54	-9.69	-24.54	30.46	5.46	-5.25	-3.35	-2.94	0.13	0.13	-4.33	6.77
	-2.13	-1.44	-28.88	-62.62	-13.13	-15.20	-4.48	-15.76	19.61	-7.75	-63.35	-20.33
Net Cash Flow	-0.82	2.74	1.95	-3.08	0.03	-0.28	-0.99	-0.38	8.28	-1.88	8.85	-6.69

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2012	Mar 2013	Jun 2014	Jun 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Debtor Days	129.23	229.07	106.92	116.29	168.57	113.32	264.99	263.07	59.04	58.04	39.07	77.72
Inventory Days	59.01	93.78	58.36	90.23	74.24	92.98	123.76	97.65	99.15	66.73	96.72	87.17
Days Payable	170.79	242.82	235.12	283.11	322.55	282.57	535.55	519.27	429.94	300.91	109.49	103.37
Cash Conversion Cycle	17.44	80.03	-69.84	-76.59	-79.74	-76.26	-146.80	-158.55	-271.75	-176.14	26.30	61.52
Working Capital Days	74.17	104.77	-152.54	-167.27	-196.30	-221.59	-456.25	-61.60	-201.22	-90.46	11.13	54.80
ROCE %	4.53%	6.89%	-1.34%	8.76%	8.87%	10.05%	-2.57%	-0.43%	-4.87%	5.32%	49.82%	3.60%

Shareholding Pattern

Numbers in percentages

1 Recently

	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Apr 2024
	20.00%	20.04%	47.79%	47.80%	47.58%	47.58%	51.00%	54.58%	54.81%	54.81%	54.81%	58.11%
	2.07%	1.13%	1.12%	0.76%	0.57%	0.37%	0.18%	0.17%	0.18%	0.17%	0.17%	0.16%
	1.85%	0.47%	1.19%	3.99%	4.00%	4.00%	3.74%	0.41%	0.41%	0.62%	0.81%	0.75%
	76.08%	78.36%	49.89%	47.45%	47.85%	48.05%	45.08%	44.84%	44.61%	44.41%	44.21%	40.98%
No. of Shareholders	20,672	27,720	26,220	26,969	28,433	28,515	26,820	27,202	26,652	26,422	25,717	25,699

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Apr 2024
	23.99%	18.66%	18.13%	19.88%	19.88%	47.79%	51.00%	54.81%	58.11%
	4.74%	3.57%	3.64%	3.50%	3.50%	1.12%	0.18%	0.17%	0.16%
	1.70%	1.01%	1.01%	0.66%	0.47%	1.19%	3.74%	0.81%	0.75%
	69.57%	76.75%	77.22%	75.96%	76.15%	49.89%	45.08%	44.21%	40.98%
No. of Shareholders	19,769	20,791	20,281	19,642	19,350	26,220	26,820	25,717	25,699

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Lyka Labs Ltd

Lyka Labs Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings